Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD
Open Access
- 20 November 2017
- journal article
- review article
- Published by Elsevier BV in Kidney International Reports
- Vol. 3 (3), 542-554
- https://doi.org/10.1016/j.ekir.2017.11.009
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Glycosylated Hemoglobin and Albumin-Corrected Fructosamine Are Good Indicators for Glycemic Control in Peritoneal Dialysis PatientsPLOS ONE, 2013
- Enter the dragon: a Chinese epidemic of chronic kidney disease?The Lancet, 2012
- Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal DiseaseYonsei Medical Journal, 2012
- The Effect of Iron and Erythropoietin Treatment on the A1C of Patients With Diabetes and Chronic Kidney DiseaseDiabetes Care, 2010
- Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patientsKidney International, 2010
- Glycated Albumin and Glycated Hemoglobin Are Influenced Differently by Endogenous Insulin Secretion in Patients With Type 2 DiabetesDiabetes Care, 2009
- Target for Glycemic Control in Type 2 Diabetic Patients on Hemodialysis: Effects of Anemia and Erythropoietin Injection on Hemoglobin A1cTherapeutic Apheresis and Dialysis, 2009
- Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes?Nature Clinical Practice Nephrology, 2008
- Glycated Albumin Is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with DiabetesJournal of the American Society of Nephrology, 2007
- Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survivalKidney International, 2006